SCOPUS 정보 검색 플랫폼

Urologia Internationalis

Volumn 66, Issue 2, 2001, Pages 84-88

Discontinuation of alpha-blockade after initial treatment with finasteride and doxazosin for bladder outlet obstruction

(3) Baldwin, Kelly C a Ginsberg, Phillip C a Harkaway, Richard C a,b

a ALBERT EINSTEIN MEDICAL CENTER (United States)

b NONE (United States)

Author keywords

Blockade, discontinuation; Bladder outlet obstruction; Doxazosin; Finasteride

Indexed keywords

DOXAZOSIN; FINASTERIDE;

ALPHA ADRENERGIC RECEPTOR BLOCKING; ARTICLE; BLADDER NECK STENOSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG WITHDRAWAL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY;

ADRENERGIC ALPHA-ANTAGONISTS; DOXAZOSIN; ENZYME INHIBITORS; FINASTERIDE; HUMANS; MALE; PROSTATIC HYPERPLASIA; URINARY BLADDER NECK OBSTRUCTION;

EID: 0035104828 PISSN: 00421138 EISSN: None Source Type: Journal
DOI: 10.1159/000056576 Document Type: Article

Times cited : (17)

References (14)

1
- 0021149603
- The development of human benign prostatic hyperplasia with age
- (1984) J Urol , vol.132 , pp. 474-479
- Berry, S.J.¹ Coffey, D.S.² Walsh, P.C.³

2
- 0025861680
- High prevalence of benign prostatic hypertrophy in the community
- (1991) Lancet , vol.338 , pp. 469-471
- Garraway, W.M.¹ Collins, G.H.² Lee, R.J.³

3
- 0030249241
- Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials
- (1996) Urology , vol.48 , pp. 398-405
- Boyle, P.¹ Gould, A.L.² Roehrborn, C.G.³

4
- 0031936627
- Maximum efficacy of finasteride is obtained within 6 months
- (1998) Eur Urol , vol.33 , pp. 312-317
- Ekman, P.¹

5
- 0006075228
- The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia
- (1998) N Engl J Med , vol.338 , pp. 557-563
- McConnell, J.¹ Bruskewitz, R.² Walsh, P.³ Andriole, G.⁴ Lieber, M.⁵ Holtgrewe, L.⁶ Albertsen, P.⁷ Roehrborn, C.⁸ Nickel, C.⁹ Wang, D.¹⁰ Taylor, A.¹¹ Waldstreicher, J.¹²

6
- 0005804836
- NIH Conference on BPH, March
- (1998)

7
- 0005894497
- abstract 1407
- (1999) American Urological Association National Meeting

8
- 0005894497
- abstract 867
- (1999) American Urological Association National Meeting

9
- 9444268678
- The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia
- (1996) N Engl J Med , vol.335 , pp. 533-539
- Lepor, H.¹ Williford, W.O.² Barry, M.J.³ Brawer, M.K.⁴ Dixon, C.M.⁵ Gormley, G.⁶ Haakenson, C.⁷ Machi, M.⁸ Narayan, P.⁹ Padley, R.J.¹⁰

10
- 0029340850
- A trial of the use of finasteride and terazosin in patients with benign prostatic hyperplasia
- (1995) Urol Nefol (Mosk) , vol.4 , pp. 32-35
- Diu, P.¹ Kosko, D.V.² Loran, O.B.³ Kan, Ia.D.⁴ Sapozhnikov, I.M.⁵ Tevlin, K.P.⁶

11
- 0001873437
- Peak flow and IPSS changes in patients treated with a combination of finasteride and terazosin after withdrawing terazosin
- (1997) Br J Urol , vol.80 , pp. 208
- Pushkar, D.U.¹ Kosko, J.W.² Loran, O.B.³

12
- 0031891816
- Comparative study of therapeutic effect of dibenyline, finasteride, and combination drugs for symptomatic benign prostatic hyperplasia
- (1998) Urol Int , vol.60 , pp. 85-91
- Kuo, H.C.¹

13
- 0005880558
- Results of PREDICT (Prospective Randomized European Doxazosin and Combination) study of medical therapy for BPH
- (1999) Br J Urol Int , vol.83 , Issue.SUPPL. 4 , pp. 202-204
- Kirby, R.¹ Boyle, P.² Roehrborn, C.³

14
- 0000106241
- Combination medical therapy for symptomatic benign prostatic hyperplasia
- (1998) Can J Urol , vol.5 , pp. 578-584
- Savage, S.¹ Spungen, A.² Galea, G.³ Britanicao, J.⁴ Vapnek, J.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.